Movano Inc. (MOVE)

Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring

Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces it has successfully validated the functionality of its proprietary and patented system-on-a-chip (SoC). At 4 mm x 6.7 mm, the SoC combines multiple antennas and a variety of frequencies in the smallest ever radio frequency (RF)-enabled integrated circuit (IC) designed specifically for blood pressure or glucose monitoring systems. Movano built the integrated sen

Movano Inc. Provides Business Update and Reports First Quarter 2022 Financial Results

Today, Movano Inc. (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, reported financial results for the three months ending March 31, 2022 and provided a business update.

• 
  Standard Mercantile Acquisition Corp. Announces 2022 First Quarter Results

  CNW Group
• 
  Bausch + Lomb Corporation Files Financial Statements for the First Quarter of 2022

  CNW Group

Movano Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

Movano, a healthcare solutions company at the intersection of medtech and consumer devices, has joined the American Heart Association Center for Health Technology & Innovation's (the Center) Innovators' Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.